לבטיראצטם טבע ® 1000 מ"ג

국가: 이스라엘

언어: 히브리어

출처: Ministry of Health

유효 성분:

LEVETIRACETAM 1000 MG

제공처:

TEVA PHARMACEUTICAL INDUST.LTD

ATC 코드:

N03AX14

약제 형태:

TABLETS

관리 경로:

PER OS

Manufactured by:

TEVA PHARMACEUTICAL INDUSTRIES LTD

치료 그룹:

LEVETIRACETAM

치료 징후:

- Levetiracetam is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - Levetiracetam is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.- Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patient from 16 years of age with newly diagnosed epilepsy.- Levetiracetam is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

승인 날짜:

2009-09-01